No Detail Found!

Oxytocin infusion is a safe uterine bleeding controller alternative to blood transfusion in patients undergoing abdominal myomectomy

Author(s)
Hisham Nasief Department of Obstetrics and Gynecology, Faculty of Medicine, King Abdulaziz University Jeddah,,Saudi Arabia
Nashwa AlDardeir Department of Obstetrics and Gynecology, Faculty of Medicine, King Abdulaziz University,Jeddah,Saudi Arabia
Khalid Khadawardi Department of Obstetrics and Gynecology, Faculty of Medicine, Umm-Alqura University,Mecca,Saudi Arabia
Ahmad B. Alwazzan Department of Obstetrics and Gynecology, Faculty of Medicine, King Abdulaziz University Jeddah,,Saudi Arabia
Haneen Alothmani Department of Obstetrics and Gynecology, King Abdulaziz University Hospital,Jeddah,Saudi Arabia
Ziyad Hammad Department of Obstetrics and Gynecology, King Abdulaziz University Hospital,Jeddah,Saudi Arabia
Amber Hassan European School of Molecular Medicine, Università Degli Studi Di Milano, Milan / Translational Neuroscience Lab, CEINGE Biotecnologie Avanzate S.c.a.rl.Via Gaetano Salvatore, 486, 80145 - Naples, Italy;
Abstract
Background & objective: Uterine bleeding is a notable complication that can occur after the surgical removal of uterine fibroids, and oxytocin infusion has been a commonly used method to control blood loss in such cases. The objective of this study was to evaluate the effectiveness of oxytocin infusion in managing surgical bleeding following abdominal myomectomy, as an alternative to immediate blood transfusion. Methodology: The study population consisted of 120 patients who experienced acute blood loss following abdominal myomectomy. These patients were divided into two groups: Group A, which included 50 patients who received an oxytocin infusion, and Group B, which included 60 patients who received a placebo. All myomectomies were conducted according to department protocols, and various variables related to the study were recorded. Postoperative hemoglobin levels were checked in every patient. Results: In Group A, the average blood loss was 470.02 ± 81.65 ml, while in Group B, it was 721.42 ml ± 63.55 ml (P < 0.0001). The need for urgent blood transfusion was significantly lower in Group A (3.3%) compared to Group B (20.0%), (P = 0.044). Postoperative hemoglobin levels also showed a significant difference between the two groups, with Group A demonstrating better results than Group B. Conclusion: Oxytocin infusion can be safely used for managing blood loss in patients undergoing abdominal myomectomy. However, in cases where oxytocin is unable to effectively control the bleeding, blood transfusion may be needed as a means to compensate for the blood loss.
Publication Details
Page(s) 151-157
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 28, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
Oxytocin, Myomectomy, Surgical blood loss, Uterine leiomyomas
References
Akinyemi BO,Adewoye BR,Fakoya TA,Orlando MS,Kho RM. Laparoscopic,Myomectomy RM. Laparoscopic,Single-Port Laparoscopy RM. Laparoscopic .2022 .Uterine fibroid: a review. Niger J Med, 13(4) : 27-41.
Lee SR,Kim JH,Kim S,Kim SH,Chae HD . .The number of myomas is the most important risk factor for blood loss and total operation time in robotic myomectomy: analysis of 242 cases. 2021 Jun, 10(13) : 2930.
.2018 .. , : 127.
Taylor A,Sharma M,Tsirkas P,Di Spiezio Sardo A,Setchell M,Magos A .2004 .Reducing blood loss at open myomectomy using triple tourniquets: a randomised controlled trial. BJOG, 00430(3) : 0528-5.
Albazee E,Sayad R,Elrashedy AA,Samy Z,Faraag E,Baradwan S .2022 .Efficacy of oxytocics on reducing intraoperative blood loss during abdominal myomectomy: A systematic review and meta-analysis of randomized placebocontrolled trials. J Gynecol Obstet Hum Reprod, : .
May . .. , 51(5) : 102358.
.2022 .. , : .
Ahmad A,Kumar M,Bhoi NR,Khan Akhtar J,MI Akhtar J . .Diagnosis and management of uterine fibroids: current trends and future strategies. 2023 Mar, 30(3) : 0219-310.
Tinelli A,Favilli A,Lasmar RB,Mazzon I,Gerli S,Xue X .2019 .The importance of pseudocapsule preservation during hysteroscopic myomectomy. Eur J Obstet Gynecol Reprod Biol, 09 : 179-184.
Tinelli A,Vinciguerra M,Sparić R,Hatırnaz Ş,Güler O,Kosmas I .2023 .Fibroids in Obstetrics and Gynecology: Training and Skill in Myomectomy. , : 981-1025.
Vinciguerra M,Sparic R,Hartinaz S,Trojano G,Tinelli A .2020 .Cesarean myomectomy technique: a critical review. J Interdisciplinary Res Appl Med, 4(1) : 25-36.
Ahmed M,Baqai S,Khushdil A,Ahmed F . .Effect of oxytocin infusion on reducing blood loss during abdominal myomectomy: A randomized controlled trial. J Pak Med Assoc, 70(6) : 969-972.
Niaz S,Abid S,Ashraf A,Mumtaz N . .. Efficacy of Oxytocin in Reducing Blood Loss During Abdominal Myomectomy. Proceedings; 2022., : .
Ahmed M,Baqai S,Khushdil A,Ahmed F . .Effect of oxytocin infusion on reducing blood loss during abdominal myomectomy: A randomized controlled trial. J Pak Med Assoc, 70(6) : 969-972.
0

Citations

0

Downloads

48

Views